Urogen pharma to present at td cowen: 6th annual oncology innovation summit: insights for asco & eha

Princeton, n.j.--(business wire)--urogen pharma ltd. (nasdaq: urgn), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a fireside chat at the td cowen: 6th annual oncology innovation summit: insights for asco & eha to take place on may 27-28, 2025. td cowen: 6th annual oncology innovation summit: insights for asco & eha date / time: may 28, 2025, at 9:00 am et format.
COWN Ratings Summary
COWN Quant Ranking